Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

被引：0
作者：
F. J. Lavalle-González
A. Januszewicz
J. Davidson
C. Tong
R. Qiu
W. Canovatchel
G. Meininger
机构：
[1] Universidad Autonóma de Nuevo León,Endocrinology and Internal Medicine Department
[2] Institute of Cardiology,Department of Hypertension
[3] University of Texas Southwestern Medical School,Department of Medicine
[4] Janssen Research & Development,undefined
[5] LLC,undefined
来源：
Diabetologia | 2013年 / 56卷
关键词：
Canagliflozin; Metformin; Sitagliptin; Sodium glucose co-transporter 2 (SGLT2) inhibitor; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2582 / 2592
页数：10
相关论文
共 50 条
[41]   Randomized trial assessing the safety and efficacy of sitagliptin in Chinese patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea alone or combined with metformin [J].
Ba, Jianming ;
Han, Ping ;
Yuan, Guoyue ;
Mo, Zhaohui ;
Pan, Changyu ;
Wu, Fan ;
Xu, Lei ;
Hanson, Mary E. ;
Engel, Samuel S. ;
Shankar, R. Ravi .
JOURNAL OF DIABETES, 2017, 9 (07) :667-676
[42]   Economic evaluation of canagliflozin versus glimepiride and sitagliptin in dual therapy with metformin for the treatment of type 2 diabetes in Italy [J].
Ravasio, Roberto ;
Pisarra, Patrizia ;
Porzio, Roberto ;
Comaschi, Marco .
GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2016, 3 (02) :92-101
[43]   Safety of Canagliflozin in Patients with Type 2 Diabetes [J].
Mikhail, Nasser .
CURRENT DRUG SAFETY, 2014, 9 (02) :127-132
[44]   Efficacy of Dapagliflozin plus Sitagliptin plus Metformin Versus Sitagliptin plus Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial [J].
Singh, Awadhesh Kumar ;
Das, Ashok Kumar ;
Murthy, L. Sreenivasa ;
Ghosal, Samit ;
Sahay, Rakesh ;
Harikumar, K. V. S. ;
Keshava, Ganesh Hosahithlu ;
Agarwal, Mayur ;
Vijayakumar, G. ;
Kalra, Pramila ;
Lodha, Piyush ;
Das, Sambit ;
Shaikh, Shehla ;
Goswami, Soumik ;
Ajish, T. P. ;
Kumthekar, Prashant ;
Upadhyay, Mihir ;
Thamburaj, Anthuvan ;
Mahule, Aushili ;
Prasad, Ashish ;
Pednekar, Abhijit .
ADVANCES IN THERAPY, 2025, 42 (02) :801-812
[45]   COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA [J].
Sabapathy, Suthakar ;
Neslusan, Cheryl ;
Yoong, Kim ;
Teschemaker, Anna ;
Johansen, Pierre ;
Willis, Michael .
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2016, 23 (02) :E151-E168
[46]   Efficacy and Safety of Sitagliptin in the Treatment of Type 2 Diabetes [J].
Gadsby, Roger .
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 :53-62
[47]   Efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in patients with type 2 diabetes A systematic review and meta-analysis [J].
Li, Mingxing ;
Yang, Yi ;
Jiang, Deqi ;
Ying, Miaofa ;
Wang, Yong ;
Zhao, Rui .
MEDICINE, 2017, 96 (39)
[48]   Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes [J].
Fulcher, G. ;
Matthews, D. R. ;
Perkovic, V. ;
de Zeeuw, D. ;
Mahaffey, K. W. ;
Mathieu, C. ;
Woo, V. ;
Wysham, C. ;
Capuano, G. ;
Desai, M. ;
Shaw, W. ;
Vercruysse, F. ;
Meininger, G. ;
Neal, B. .
DIABETES OBESITY & METABOLISM, 2016, 18 (01) :82-91
[49]   Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise [J].
Stenlof, K. ;
Cefalu, W. T. ;
Kim, K. -A. ;
Alba, M. ;
Usiskin, K. ;
Tong, C. ;
Canovatchel, W. ;
Meininger, G. .
DIABETES OBESITY & METABOLISM, 2013, 15 (04) :372-382
[50]   The efficacy and safety of teneligliptin added to ongoing metformin monotherapy in patients with type 2 diabetes: a randomized study with open label extension [J].
Bryson, Andrew ;
Jennings, Paul E. ;
Deak, Laszlo ;
Paveliu, Fraga S. ;
Lawson, Matt .
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (10) :1309-1316
12345